On Tuesday, Elanco Animal Health Incorporated (NYSE:ELAN) used its first Investor Day in five years to signal a turning point for the company, outlining a more focused strategy aimed at sustainable growth, margin expansion, and a stronger balance sheet. CEO…
Natera Inc. (NASDAQ:NTRA) on Wednesday revealed initial translational research results from the international randomized Phase 3 PALLAS study. Data were presented at the San Antonio Breast Cancer Symposium (SABCS). These first data, generated from a U.S. biomarker cohort of 420…
Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock is higher on Thursday, after the company shared preliminary results from its exploratory Phase 2 trial of setmelanotide in patients with Prader-Willi syndrome (PWS). PWS is a rare genetic disorder characterized by muscle weakness and…
PayPal Holdings Inc (NASDAQ:PYPL) shares are trading higher on Thursday, bouncing back from earlier losses after BofA Securities cut its rating from Buy to Neutral and lowered its price target to $68 from $93. PayPal Holdings stock is showing downward…
The National Medical Products Administration (NMPA) in China has approved Sanofi SA’s (NASDAQ:SNY) two medicines for rare hematologic diseases: Qfitlia (fitusiran) for hemophilia and Cablivi (caplacizumab) for acquired thrombotic thrombocytopenic purpura. • Sanofi stock is showing upward movement. Why is…
XOMA Royalty Corporation (NASDAQ:XOMA) stock plunged on Thursday after its partner Rezolute Inc. (NASDAQ:RZLT) reported disappointing trial results for its partnered product, Ersodetug (RZ358). The company on Thursday released topline results from its Phase 3 sunRIZE study evaluating ersodetug in…
Wall Street analysts rerated Synopsys, Inc (NASDAQ:SNPS) after it reported its quarterly results on Wednesday. • Synopsys stock is trading in a tight range. What should traders watch with SNPS? Synopsys reported stronger-than-expected fourth-quarter results, posting adjusted earnings of $2.90…
Visa Inc. (NASDAQ:V) stock is on the rise Thursday after Bank of America Securities upgraded its rating on the stock. Visa stock is among today’s top performers. What’s driving V stock higher? What To Know: Analyst Mihir Bhatia upgraded Visa from…
GE Vernova’s (NYSE:GEV) latest Investor Day refreshed expectations with sharper financial targets and a more defined strategic roadmap, prompting analysts to reassess the company’s long-term trajectory. Seaport Global analyst Tom Curran now considers GEV fairly valued following the December 9…
When it comes to judging the health of the stock market and new all-time records being set, most investors track the Dow Jones Industrial Average, S&P 500 and Nasdaq 100. President Donald Trump showed which of these metrics he prefers…